Rite Aid – Walgreens Merger Shelved
Having failed to secure Federal Trade Commission (FTC) approval, Rite Aid and Walgreens Boots Alliance have scuttled plans to merge. Instead, Walgreens will acquire 2,186 Rite Aid stores and three distribution centers for $5.175 billion in cash. Under this deal, Walgreens will pay a break-up fee of $325 million and allow Rite Aid to buy generic medication sourced by Walgreens for a 10-year period, according to InvestorPlace. These adverse consequences really should be taken as and when prescribed for better and faster levitra brand results. Chronic pancreatitis does not suddenly falls from the sky. purchase cialis Sildenafil citrate is available in different forms such as Oral Jelly, Soft Tabs, Polo and Fizz. soft generic viagra However, there are some other factors that may cause this dysfunction to occur consistently and being harassed by this shameful sexual inability one is required to seek for alternate buying viagra in italy measures. Rite Aid’s U.S. prescription revenue market share is 4.8 percent, compared to 14.8 percent for CVS and 13.8 percent for Walgreen’s, according to The Motley Fool (citing data from Drug Channels). As of Friday, Rite Aid stock was trading at $2.37/share.
Last Updated on July 9, 2017 by Ramin Seddiq